L Brevis for Traumatic Oral Lesions in Orthodontic Patients

• Status: Completed
• Trial end date: 2019-12-13
• Target enrollment: 0
• Participant gender: All

Summary

Introduction: Traumatic oral lesions are common in the beginning of the orthodontic treatment, and pathogenic oral bacteria might be involved. We tested whether the probiotic Lactobacillus brevis CD2 (L brevis) is benefic in this condition. Methods: In a double-blind clinical trial, 20 patients were randomized to 21 days course of lozenges containing L brevis CD2 (4 billion colony-forming units after breakfast, lunch and dinner) or placebo, starting on the day of installation of the fixed orthodontic appliance. Main outcomes were days without oral lesions and oral pain score [ranging between 0 (no pain) and 10 (maximum)]. Oral health related quality of life was measured by OHIP-14 before and after treatments.

• Phase: Phase 2
• Accepts Healthy Volunteers?: No

Details

• Lead Sponsor: Universidade de Passo Fundo
• Collaborator: Coordenação de Aperfeiçoamento de Pessoal de Nível Superior.

Criteria

Inclusion Criteria:

• need for orthodontic treatment with fixed appliance

Exclusion Criteria:

• Oral lesions

• Uncompensated systemic diseases

• Regular use of corticoids, antibiotics, immuno regulators and antidepressive agents